ADMINISTRATION ABSTRACT The UCLA Jonsson Comprehensive Cancer Center (JCCC) Administration provides central organization and supports infrastructure required to facilitate the ongoing mission, scientific initiatives, and long-term vision of the Center. Administration activities support Center business operations and the JCCC Director and Senior Leaders, Research Programs, Shared Resources, Clinical Components, Community Outreach and Engagement Core, the Office of Cancer Training and Education, and JCCC membership. Led by the Associate Director for Administration, the administrative team includes 24 full time equivalent (FTE) staff, with duties and assignments distributed between six units. These units are (1) the Business Office, (2) Director?s Office and Administrative Support, (3) the Office of Communications, (4) Informatics, (5) Information Technology (IT) and Website, and (6) the Office of Cancer Training and Education. Collectively, these six Administration units facilitate Center operations and strategic initiatives, and provide a wide-range of services to Center constituents that foster cancer focused research, productivity, and collaborations. The purview of Administration includes oversight of the NCI Cancer Center Support Grant (CCSG) and all associated reporting activities, finance and business operations, human resources (HR), informatics and IT, communications, facilities, resource allocation, coordination of programmatic and Center-wide events and meetings, membership, administrative management of the Office of Cancer Education and Training, and support for implementation of JCCC planning and evaluation activities, including the 2019 ? 2023 JCCC Strategic Plan. To support these areas, Administration divides its activities into five specific aims.
Aim 1 is to facilitate planning and evaluation activities, including implementation of the 2019 ? 2023 JCCC Strategic Plan, and to support programmatic and Center-wide activities that enable scientific productivity and promote collaborations and team science.
Aim 2 is to provide robust financial management and to oversee allocation of resources to enhance Center achievement of its objectives, mission, and long-term vision.
Aim 3 is to provide essential informatics and IT services to support research operations.
Aim 4 is to communicate effectively, both to internal and external audiences, Center accomplishments and opportunities available to JCCC members to support cancer-focused research.
Aim 5 is to manage Center membership and facilitate data-driven evaluations of new member applications, with yearly re-evaluations of existing members based upon formal JCCC membership criteria.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016042-44
Application #
9936711
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Tsang, Eric J; Wu, Benjamin; Zuk, Patricia (2018) MAPK signaling has stage-dependent osteogenic effects on human adipose-derived stem cells in vitro. Connect Tissue Res 59:129-146
Waters, Lynnea R; Ahsan, Fasih M; Wolf, Dane M et al. (2018) Initial B Cell Activation Induces Metabolic Reprogramming and Mitochondrial Remodeling. iScience 5:99-109
Van Dyk, Kathleen; Bower, Julienne E; Crespi, Catherine M et al. (2018) Cognitive function following breast cancer treatment and associations with concurrent symptoms. NPJ Breast Cancer 4:25
Robinett, Ryan A; Guan, Ning; Lux, Anja et al. (2018) Dissecting Fc?R Regulation through a Multivalent Binding Model. Cell Syst 7:41-48.e5
Chin, Chee Jia; Li, Suwen; Corselli, Mirko et al. (2018) Transcriptionally and Functionally Distinct Mesenchymal Subpopulations Are Generated from Human Pluripotent Stem Cells. Stem Cell Reports 10:436-446
Alban, Tyler J; Alvarado, Alvaro G; Sorensen, Mia D et al. (2018) Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis. JCI Insight 3:
Yang, Qing; Fung, Wing K; Li, Gang (2018) Sample size determination for jointly testing a cause-specific hazard and the all-cause hazard in the presence of competing risks. Stat Med 37:1389-1401
Seo, Jai Woong; Tavaré, Richard; Mahakian, Lisa M et al. (2018) CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols. Clin Cancer Res 24:4976-4987
Ribas, Antoni; Wolchok, Jedd D (2018) Cancer immunotherapy using checkpoint blockade. Science 359:1350-1355
Wang, Hong; Chen, Xiaolin; Li, Gang (2018) Survival Forests with R-Squared Splitting Rules. J Comput Biol 25:388-395

Showing the most recent 10 out of 767 publications